Gland Pharma Limited is an India-based generic injectable-focused company. The Company specializes in complex injectables and is engaged in the sterile injectables, oncology, and ophthalmology segments. The Company provides contract development, own development, dossier preparation and filing, technology transfer and manufacturing across a variety of delivery systems. Its products are available in liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags, and drops. Its key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Blood Related, Cardiac, Gastrointestinal, Gynaecological, Hormones, Neuro / Cns, Ophthal / Otologicals, Pain/Analgesics, Respiratory and Vitamins / Minerals / Nutrients. Its products are sold across various countries, which include United States, Europe, Canada, and others.

Company Officers

Srinivasa Sadu
Chief Executive Officer, Managing Director, Whole-Time Director
Ravi Mitra
Chief Financial Officer
Prakash Baliga
Chief Operating Officer
P. Sampath Kumar
Compliance Officer, Company Secretary
Ankit Gupta
Vice President- Strategy and Investments